BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Pain clinical trials and catalysts

Active industry-sponsored trials on ClinicalTrials.gov for pain: 393 (277 sponsors; 96 newly posted in the last 180 days, 16 stopped in the last 180 days; 63 new-entrant sponsors). Momentum score 18.4, rank 32 of 91 on the disease-area ranking. As of 2026-11-18.

Phase distribution: Early Phase 1 6, Phase 1 32, Phase 2 53, Phase 3 59, Phase 4 10, N/A 233.

Most active sponsors, by phase

SponsorActive trialsBy phaseNew (window)Upcoming readouts
Eli Lilly and Company LLY9P3 4, P2 523
EMS4P3 401
Vertex Pharmaceuticals Incorporated VERX4P3 3, P2 103
Ambros Therapeutics, Inc.3P3 2, NA 120
Novo Nordisk A/S NVO3P3 2, P1 111
Pfizer PFE3P2 1, P3 221
AFT Pharmaceuticals, Ltd.2P3 201
Shanghai Huilun Pharmaceutical Co., Ltd. new entrant2P3 220
Haisco Pharmaceutical Group Co., Ltd.3P3 1, P2 201
AbbVie ABBV2NA 1, P3 101
Adneuris Therapeutics, Inc. new entrant2P3 1, P2 122
Amgen AMGN2P3 1, NA 100
Gelscom SAS2P3 1, NA 100
Genascence Corporation2P1 1, P3 110
TLC Biopharmaceuticals, Inc.2P2 1, P3 100
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.2P1 1, P3 110
Ache Laboratorios Farmaceuticos S.A. new entrant1P3 111
Aponia Laboratories, Inc. new entrant1P3 110
Asklepion Pharmaceuticals, LLC1P3 100
Avenue Therapeutics, Inc. ATXI1P3 100
Brainfarma Industria Química e Farmacêutica S/A new entrant1P3 110
Cali Pharmaceuticals LLC1P3 100
Dexa Medica Group new entrant1P3 111
DiscGenics, Inc.1P3 100
Ensysce Biosciences ENSC1P3 100

New-entrant sponsors: Shanghai Huilun Pharmaceutical Co., Ltd., Adneuris Therapeutics, Inc., Ache Laboratorios Farmaceuticos S.A., Aponia Laboratories, Inc., Brainfarma Industria Química e Farmacêutica S/A, Dexa Medica Group.

Recently stopped trials

Upcoming trial readouts (next 90 days)

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-11-22 est.P2Haisco Pharmaceutical Group Co., Ltd.NCT07533786 A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal SurgeryPain After Surgeryrecruiting200
2026-11-30 est.P3Saol Therapeutics IncNCT07226258 Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee PainOsteoarthritis Knee Painactive not recruiting150
2026-12 est.P23D MedicinesNCT05265052 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer PainCancer Painnot yet recruiting177
2026-12 est.P2Dianthus Therapeutics DNTHNCT06537999 A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor NeuropathyMultifocal Motor Neuropathyactive not recruiting46
2026-12 est.P2Dogwood Therapeutics Inc. DWTXNCT06848348 Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainChemotherapy Induced Neuropathic Pain; Chemotherapy Induced Pain Neuropathy; Chemotherapy Induced Paactive not recruiting240
2026-12 est.P3Harrow Inc HROWNCT07832552 A Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) for the Treatment of Ocular Inflammation and Pain After Ophthalmic SurgPostoperative Ocular Inflammation; Postoperative Ocular Painenrolling by invitation250
2026-12-15 est.P2/P3Janssen Research & Development, LLCNCT05327114 Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Polyradiculoneuropathy, Chronic Inflammatory Demyelinatingrecruiting201
2026-12-31 est.P2/P3Olatec Therapeutics, Inc.NCT05658575 Study of Dapansutrile Tablets in Subjects With an Acute Gout FlareAcute Gout Flare; Gout Attack; Gout Flare; Gouty Arthritis; Gout; Arthritis; Joint Painrecruiting300
2027-01 est.P3Adneuris Therapeutics, Inc.NCT07845071 An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical OriginPainrecruiting160
2027-01-20 est.P1/P2Creative Medical Technology Holdings Inc CELZNCT06053242 Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back PainChronic Low-back Pain; Degenerative Disc Diseaseactive not recruiting45
2027-01-25 est.P3Vertex Pharmaceuticals Incorporated VERXNCT06696443 Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)Diabetic Peripheral Neuropathic Painactive not recruiting455

Readouts in the last 180 days

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-11 est.P2Haisco Pharmaceutical Group Co., Ltd.NCT07551739 A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic SurgeryPain After Surgerynot yet recruiting200
2026-11 est.P2Eli Lilly and Company LLYNCT07511816 A Study of LY4515100 in Participants With Pain Following Third Molar RemovalAcute Pain; Molar; Molar, Third; Surgery, Oralrecruiting212
2026-11 est.P1/P2Bexion Pharmaceuticals, Inc.NCT05322590 BXQ-350 in Newly Diagnosed Metastatic Colorectal CarcinomaMetastatic Colorectal Carcinoma; Neuropathyactive not recruiting195
2026-10-04P2Bausch & Lomb Incorporated BLCONCT07412496 A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive KeratectomyPain, Postoperativecompleted130
2026-10-01P2Nuvig Therapeutics, Inc.NCT07027111 Safety, Tolerability, and Efficacy of NVG-2089 in Participants With CIDPChronic Inflammatory Demyelinating Polyneuropathyterminated14
2026-10 est.P2/P3Shanghai Huilun Pharmaceutical Co., Ltd.NCT07709598 Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Abdominal SurgeryPostoperative Painrecruiting330
2026-10 est.P2/P3Shanghai Huilun Pharmaceutical Co., Ltd.NCT07699601 Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic SurgeryPostoperative Painrecruiting330
2026-10 est.P2Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.NCT07159243 Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic PainDiabetic Peripheral Neuropathic Painnot yet recruiting180
2026-09-30 est.P2Tarian PharmaNCT07082764 Safety and Efficacy Study of TAR-0520 Gel in Prevention of Taxane-induced Peripheral NeuropathyChemotherapy Induced Peripheral Neuropathynot yet recruiting30
2026-09 est.P3Qilu Pharmaceutical Co., Ltd.NCT06994507 GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast CancerChemotherapy-induced Peripheral Neuropathy (CIPN)recruiting352
2026-09 est.P3argenx ARGXNCT06742190 A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor NeuropathyMultifocal Motor Neuropathy (MMN); MMNactive not recruiting154
2026-09 est.P3Eidos Therapeutics, a BridgeBio companyNCT04882735 Efficacy and Safety of Acoramidis (AG10) in Subjects with Transthyretin Amyloid Polyneurophathy (ATTRibute-PN)Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathywithdrawn
2026-08 est.P3Ensysce Biosciences ENSCNCT06602271 PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)Postoperative Pain, Acuterecruiting320
2026-07-20P2Immunovant Sciences GmbH IMVTNCT05581199 To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDPChronic Inflammatory Demyelinating Polyneuropathyterminated94
2026-07-16P2Immunovant Sciences GmbH IMVTNCT07188844 An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)Chronic Inflammatory Demyelinating Polyneuropathyterminated26
2026-07 est.P2TLC Biopharmaceuticals, Inc.NCT06574269 A Study on TLC590 for Managing Postsurgical PainPostsurgical Pain Managementrecruiting120
2026-06-26P2Novo Nordisk A/S NVONCT06797869 A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral NeuropathyDiabetes Mellitus, Type 2; Diabetic Peripheral Neuropathycompleted142
2026-06-17P2SoLa Pelvic TherapyNCT06673108 Vaginal Photobiomodulation for Chronic Pelvic PainChronic Pelvic Pain; Chronic Pelvic Pain Syndrome (CPPS)completed128
2026-06-12P3TLC Biopharmaceuticals, Inc.NCT07222748 A Study of TLC590 for Postsurgical Pain Following BunionectomyPostoperative Painactive not recruiting304
2026-06-10P3Sanofi SNYNCT06290128 A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Chronic Inflammatory Demyelinating Polyradiculoneuropathy; Polyneuropathy, Inflammatory Demyelinatinactive not recruiting109
2026-06 est.P2Vaneltix Pharma, Inc.NCT06394830 Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)Interstitial Cystitis; Bladder Pain Syndromerecruiting50
2026-06 est.P2Vaneltix Pharma, Inc.NCT05737121 Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPSInterstitial Cystitis; Bladder Pain Syndromerecruiting120
2026-06 est.P2Sound Pharmaceuticals, Incorporated SOGPNCT01451853 SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing LossLung Cancer; Head and Neck Cancer; Hearing Loss; Ototoxicity; Tinnitus; Neuropathywithdrawn
2026-05-26P2Syqe MedicalNCT06490445 A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)Diabetic Peripheral Neuropathic Paincompleted122

Landscape counts: ClinicalTrials.gov, industry lead sponsors, active statuses, via the free hosted BioCatalystFeed MCP tool condition_landscape (query "pain"); readouts matched by condition text. Registry counts only; not a forecast.

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.